Science News

BrightFocus is funding a clinical trial to try to fight glaucoma with a new drug implanted in the eye that may protect the optic nerve.

Jeffrey Goldberg, MD, PhD, a BrightFocus grantee answers questions about an exciting new clinical trial for glaucoma.

More and more people are paying attention to lifestyle changes aimed at keeping the brain healthy, and helping to keep Alzheimer’s at bay. Not a total solution, but one that could help.

BrightFocus-funded research, along with our national and international connections, are on display at major Alzheimer’s conference.

A small layer of tissue lying next to the retina, called the RPE, may serve as a tipping point in AMD. Read about BrightFocus-funded research on display at ARVO 2016.

Why do immune sensors known as toll-like receptors (TLRs) become activated and contribute to the AMD disease process? Also read our profile of Doyle and her husband, BrightFocus grantee Matthew Campbell, PhD.

Ken Dychtwald believes there’s something missing in this presidential campaign season, and he’s not talking about courtesy. As president and CEO of AgeWave, a California-based thought leader, he wants to know where candidates stand on aging issues.